Clinical trial
Safety and Efficacy Study of the Investigational Drug Pagoclone, in the…
NCT00239915 · Pharmacology Research Institute, Other · Completed
Key facts
| NCT number | NCT00239915 |
|---|---|
| Title | Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS) |
| Official title | An 8-week, Double-Blind, Randomized, Multicenter, Flexible-Dose, Placebo-Controlled Pilot Study of Pagoclone in Patients With Persistent Developmental Stuttering Followed by a 52-week Open-Label Extension. |
| Lead sponsor | Pharmacology Research Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Persistent Developmental Stuttering |
| Intervention type | Drug |
| Interventions | Pagoclone |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | May 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: